A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression is a research paper published in The International Journal of Neuropsychopharmacology (2020). On theSindex it has a DataRank of 1.6. It has been cited 62 times, with 49 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.621
From this paper's citation signal
Citation Network Contribution
0.945
From 43 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 49 citers.
National Institute of Mental Health
Grant: ZIAMH002857
National Institute of Mental Health
Grant: NCT02484456
BLRD VA
Grant: I01 BX003631
NIMH NIH HHS
Grant: R01 MH107615
BLRD VA
Grant: I01 BX004062
National Institutes of Health
Grant: 1ZIAMH002857-06
Glutamatergic Modulators for Rapid & Sustained Antidepressant Effect
National Institutes of Health
FWCI
2.52
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals